OCULAR THERAPEUTIX, INC

For the period ended Dec 31, 2025. Filed Feb 5, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 5, 2026

OCUL$6.85+3.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(In thousands, except share and per share data)


· · December 31, · · December 31,
· · 2025 · · 2024
Assets
Current assets:
Cash and cash equivalents	$737,060	$392,102
Accounts receivable, net	30,650	32,388
Inventory	3,564	3,040
Prepaid expenses and other current assets	10,855	13,457
Total current assets	782,129	440,987
Property and equipment, net	19,676	9,389
Restricted cash	1,614	1,614
Operating lease assets	4,638	5,945
Total assets	$808,057	$457,935
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$4,154	$4,176
Accrued expenses and other current liabilities	43,835	35,117
Deferred revenue	—	128
Operating lease liabilities	2,817	1,933
Total current liabilities	50,806	41,354
Other liabilities:
Operating lease liabilities, net of current portion	2,815	5,345
Derivative liability	13,903	13,246
Deferred revenue, net of current portion	14,000	14,000
Notes payable, net	71,336	68,505
Other non-current liabilities	887	141
Total liabilities	153,747	142,591
Commitments and contingencies (Note 18)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at December 31, 2025 and December 31, 2024, respectively	—	—
Common stock, $0.0001 par value; 400,000,000 and 400,000,000 shares authorized and 215,927,600 and 157,749,490 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively	22	16
Additional paid-in capital	1,811,311	1,206,412
Accumulated deficit	(1,157,023)	(891,084)
Total stockholders’ equity	654,310	315,344
Total liabilities and stockholders’ equity	$808,057	$457,935

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.